RetractedArticleDrug design, development and therapy2018

Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation.

Xiao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.